CambridgeIP

Health & Life Sciences

Our experience in the Health & Life Sciences includes work with major pharmaceutical companies, service providers, academic research institutes & individual inventors.

Featured Health & Life Sciences Publication

 

Download the latest Health & Life Sciences report from CambridgeIP and UK Intellectual Property office on ‘Emerging patent thickets and standards in the medical devices and telehealth space: Innovation market dynamics and policy options in cross-over technologies’.

Featured Health & Life Sciences Presentation

 

Download a Featured Health & Life Sciences Presentation from CambridgeIP on ‘The HFA pMDI Patent Landscape: Minefield or Goldmine’.

Experience and Expertise

Our team covers a broad section of the Health & Life Sciences field. We have developed particular expertise in the following fields:
  • Medical Devices
  • Diagnostics
  • Active Pharmaceutical Ingredients
  • Pharmaceutical Formulations
  • Manufacturing Processes
  • Generics
  • Over-the-counter Drugs
  • Vaccines
  • Gene Therapy
  • Regenerative Medicine
  • Contact us for a full list of our expertise

Solutions for our Clients

Clients use our analysis to meet a range of business development requirements:

  • Understand their patent landscape
  • Gather competitive intelligence
  • Formulate R&D strategies
  • Identify collaboration & in-licensing partners
  • Enable Freedom to Operate analysis
  • Support investment cases
  • Undertake M&A due diligence
  • Open Innovation
  • Highlight Technology ‘white space’
  • Inform Investment Opportunities
  • Technology Value Chain mapping
  • Develop Technology Roadmap
  • Contact us for a full range of our business solutions



Click here to download our Health & Life Sciences brochure.

 

Featured Health & Life Sciences Boliven Landscape: What is the future of HFA pMDIs?

View our latest Health & Life Sciences Boliven Landscape™ and associated article on ‘What is the Future of HFA pMDIs?’ This article was a featured publication in Inhalation magazine that was co-authored by Ilian Iliev (CEO) and Arthur Lallement (Senior Associate) with University of Sydney academics on the topic of patent trends in the inhaler industry. The pMDI article summary and an interactive list of the relevant patents can be found on Boliven.

Case Studies

Download our case studies to see examples of how we have:

  • Informed M&A and diversification activities
  • Assisted in the rapid and reliable identification of collaboration partners
  • Provided ‘on tap’ access to IP expertise
  • Improved understanding of patent activity in emerging markets including Asia/ BRIC
  • Supported flexible and real-time decision-making

Case study – Licensing Regime Options for Established Product Platforms

Fortune 100 medical devices company asked us to help identify a transition strategy to help move an industry with a highly proprietary and litigious culture toward a more open cross-licensing approach.

Case study – Emerging Market: Strategic and Tactical Information

Major pharmaceutical company “A” approached us for assistance with developing their IP strategies in several emerging markets. With increasing numbers of end-users in the developing world and emerging economies, and increasing pressure from competitors based in these locations, our client wished to improve its monitoring of emerging competitors and to identify alliance and partnering opportunities.

Team & Contacts

Learn more about the experts that are part of the Energy and Clean Technology team on our About Us page.

Click here to contact the Health & Life Sciences team.

 

Search on Boliven.com

Search Boliven's 100 million peer-reviewed documents spanning patents, journal articles, press releases and other data sources.

CambridgeIP Newsletter

Sign up for our Email Newsletter
You are here: Home Knowledge Centre Health & Life Sciences